Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Masking requirements are now less emphasized and we seem to have convinced ourselves that life is pretty much back to normal, as in pre-pandemic. Au contraire! We are approaching 950,000 deaths in the US alone. The data in the link below is still pretty sobering. And the impact of Long-Covid has yet to be fully understood. Todos and its products and services will be in demand worldwide.
https://coronavirus.jhu.edu/map.html
Thanks Joe...lots of encouraging things to think about.
I do! I take Tollovid Max just like I did Tollovid Daily...to boost my immune system, enhance my endurance, and to lower my blood pressure and heart rate. The Max gives me more insurance against getting sick.
March 17...Proactive One2One Investor Forum...Todos one of leading companies presenting!
https://www.proactiveinvestors.com/register/event_details/390#
I think your strategy will work. It will just take time. I share your enthusiasm for Todos and I'm almost as invested as you are. Sheltering your potential gains in Roth accounts was really smart.
Very smart strategy!
Thanks, very encouraging.
Thanks...do you know how successful they have been as a marketing firm? Their web site touts some pretty big launches.
Evidently Gerald has had involvement with Mike Rea of Idea Pharma based on Twitter correspondence. See: https://www.ideapharma.com/
Is this the marketing team helping Todos launch Tollovid?
I share your sentiments...and with a few notable exceptions, I think most of the other posters do as well.
Below is an important article in the NY Times from Feb 19 on Long Covid. "Studies estimate that perhaps 10-30 percent of people infected with the coronavirus may develop long-term symptoms."
Personally, I am very thankful that Tollovid exists and has properties that help fight or ward off Long Covid. The world needs to know about Tollovid.
https://www.nytimes.com/interactive/2022/02/19/science/long-covid-causes.html?action=click&module=Well&pgtype=Homepage§ion=Health
New videos posted on YouTube today...a good marketing video and three shorts from the Flag Football game.
https://www.youtube.com/channel/UCWsJLl1iB9qlZUSicQ9e-Mg
That is a tough question. I think one of the main problems at the moment is that we are in somewhat of an information void. We haven't seen a Press Release since Jan 27 and we were used to seeing them every day or so. We are awaiting 10K and 10Q filings. We are awaiting confirmation of the NLC deal closing. We are still looking for the official rollout of the Tollovid marketing plan. Some of us are still scratching our heads about the Tollovid Daily supply chain fiasco.
On top of this we see the overall markets struggling because of Russia's actions, inflation, higher interest rates, covid, supply chain issues and a myriad of other challenges.
Are you saying that the depressed price is bizarre?
...meanwhile TOMDF stock is languishing at what seems to be bargain basement prices (yes, it can/could/might drop further), and I couldn't help picking up more shares at the 0.032 level.
Once again I generally agree with you. Like you, I'm impressed with Dr. Arad and hope that there are more opportunities to showcase her.
I generally agree with your comments. My concern in the post was that reviews of products are very important. People often make buying decisions based on these review scores and the further a product gets from a perfect five the greater the likelihood that the product will not be purchased. Unforced errors caused by sloppy customer service have to be eliminated.
Like many on this board, I'm looking forward to the official launch of marketing for Tollovid this weekend. This is a wonderful product that can improve people's lives. I just hope that Todos is prepared to execute. I've looked over reviews of Tollovid on Amazon, mytollovid.com., and Trustpilot. Universally the product gets very high marks. Unfortunately customer service has gotten some very low ratings. I thought some of the comments were overly-critical and some reviewers were just uninformed. But, eleven percent bad reviews on Trustpilot does not bode well. If you haven't submitted a strong review on Tollovid, please consider doing so.
You are right, they could extend the sale. On the other hand, if demand increases substantially as a result of the marketing roll out this weekend, then there wouldn't be a need to incentivize the purchase...providing more to the bottom line.
Just noticed that the special offer (50% off second bottle) on mytollovid.com is about to expire on Feb 13. Just ordered a couple more bottles.
Here's the link to the Jon Najarian post:
https://twitter.com/jonnajarian/status/1491760109503934464?t=B1vfcVuU-Y-X6TfhKwFFmQ&s=19
Tweet from Jon Najarian
@jonnajarian
Todos
@todosmedical
announced game-changing news that in a phase 2 clinical study, #Tollovir, an oral antiviral, showed a 100% reduction in mortality! Superiority to Remdesivir, & takes dying off the table. https://streetwisereports.com/article/2022/02/08/todos-covid-19-drug-shows-superiority-to-remdesivir-takes-dying-off-the-table.html#.YgQ5_KbswhN.twitter
@SWReports
#Investing
streetwisereports.com
Todos COVID-19 Drug Shows Superiority to Remdesivir,Takes Dying Off the Table
In a phase 2 clinical study, Todos Medical's oral antiviral Tollovir showed a 100% reduction in mortality from COVID-19.
8:05 AM · Feb 10, 2022·Twitter Web App
Jon Najarian has more than 290,000 followers on Twitter and has recently posted positive comments about Todos and Tollovid.
Right on!
Excellent point (especially for some of us with less than perfect eyesight) ...it's there but in a small font.
There are many positive benefits to Tollovid that are just now coming to light. There were numerous antidotal reports of improved conditions from the 5,000 people who received the product prior to the clinical trial of Tollovir.
You reported lower blood sugar. I find that I have more endurance and my blood pressure and heart rate are lower. Also, I've notice an improvement in my skin.
Bottom line...this product can be marketed in a number of ways even after Covid is gone...if in fact it ever leaves.
New improved look and feel to the TCELL Protect web page.
https://www.tcellprotect.com/
You are spot on! This will be quite a way to launch the Tollovid marketing blitz and is money well spent. It will give Todos much needed exposure to potential investors. But, most importantly it will introduce the public to a potentially life saving product.
True, but the volume was still very light. Don't get sick, take a Tollovid! It works for me.
Agree with your comments...Todos holding steady with light volume while the market in general is cratering.
Thanks Joe, were you buying more today. I was able to get more at 0.0365...so I'm close to break even with my dollar cost averaging.
I would certainly expect more accumulation going into the weekend. As more people become aware of Todos and Tollovid/Tollovir on Saturday and Sunday there will be more interest in the company. Monday could/should be exciting.
Thanks, you may be right, but I just think that the window of opportunity to buy Todos at these levels is closing. GC is supposed to give an update briefing today which should be pretty positive...and Todos soon will get much needed exposure to a much larger audience as they launch their marketing campaign this Saturday.
You may be right. Looks like some bottom fishing coming in today...noticed a bid for 1,000,000 shares on Level 2...and several others in the 200,000 to 300,000 share range.
This was a good article with a ton of information...thanks for the link. I thought the following quote is a foot-stomper:
The CEO had been an outspoken voice on testing and oral antivirals. He’s been on major outlets like FoxBusiness, Yahoo! Finance, Black News Channel, NTD News, Newsy, and Newsmax, to name a few chronicled on their YouTube channel. Notably missing from this list is CNBC which doesn't cover stories on companies below $100 million market cap. They have Super Bowl exposure and are the main sponsors of Celebrity Flag Football. Also on their team are Wall Street pros Peter and Jon Najarian that have endorsed TOMDF’s vision and have extremely close ties to CNBC and its producers.
This is a widely televised TV show, and investors might not be connecting the dots to FOX Sports and how big of a deal this really is. Sinclair Broadcasting bought FOX Sports in 2019 for $10 billion and then licensed it to Bally’s casino who rebranded it Bally Sports. This two-hour show will be on Direct TV and available on cable networks like Xfinity, Spectrum, Cox, AT&T, and Optimum.
There are 4.4 million subscribers to Bally Sports. Investors really could be missing the power of pre-Super Bowl advertising and how it can change the fortunes of companies that capitalize on the exposure.
The long awaited catalyst to jump start Todos may be just a few days away.
GC on Twitter in response to a request for an update:
Have been in meetings. Plan is for a full update tomorrow. In terms of outline what’s been going on: Board member was in Greece last week laying groundwork with T-Cell for Greece EUA submission. Extension of current study planned to open in Israel this month. Many patients now /1
3:11 PM · Feb 8, 2022·Twitter for iPhone
in the hospital and compassionate use requests increasing from other hospitals. Testing is steady and we are expanding our direct testing business. Tollovid record month #Tollovid ($275k+) and we are now just beginning to invest in marketing with #SuperBowl #StayInTheGame. /2....
PS Doc,
Thanks for sharing the efforts you took to help your partner fight COVID and thanks for providing information on the regimen she followed. I certainly hope that she has fully recovered.
I figured you'd think that was a loaded question. Your answer had as much or more to unpack as my query. You provided a wealth of information. Thanks for confirming a number of things for me.
We hadn't heard much from GC in a few days but he had a new interview today on BZ. Great interview with some new news.
I'm sorry, where do you see that in what I posted?